Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Short term Debt: 2010-2024

Historic Short term Debt for Lifecore Biomedical (LFCR) over the last 14 years, with Nov 2024 value amounting to $773,000.

  • Lifecore Biomedical's Short term Debt changed negligibly% to $773,000 in Q4 2024 from the same period last year, while for Nov 2024 it was $773,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $773,000 for FY2024, which is 33.28% up from last year.
  • Per Lifecore Biomedical's latest filing, its Short term Debt stood at $773,000 for Q4 2024, which was down 0.00% from $773,000 recorded in Q3 2024.
  • In the past 5 years, Lifecore Biomedical's Short term Debt ranged from a high of $99.0 million in Q4 2022 and a low of $580,000 during Q2 2023.
  • Its 3-year average for Short term Debt is $31.0 million, with a median of $773,000 in 2024.
  • In the last 5 years, Lifecore Biomedical's Short term Debt surged by 238.54% in 2022 and then plummeted by 99.41% in 2023.
  • Lifecore Biomedical's Short term Debt (Quarterly) stood at $77.0 million in 2020, then slumped by 45.45% to $42.0 million in 2021, then soared by 135.60% to $99.0 million in 2022, then plummeted by 99.22% to $773,000 in 2023, then remained steady at $773,000 in 2024.
  • Its Short term Debt was $773,000 in Q4 2024, compared to $773,000 in Q3 2024 and $773,000 in Q2 2024.